The CAVIAR trial evaluated safety and efficacy of the PCSK9 inhibitor alirocumab for prevention of cardiac allograft vasculopathy after heart transplantation. Once-weekly subcutaneous semaglutide 2.4 ...
Early-onset preeclampsia was associated with increased risk for delayed early-childhood development in the domain of problem-solving among preterm children, researchers reported.